Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.4M Buy
25,500
+17,700
+227% +$11.8M 0.01% 1273
2026
Q1
$4.25M Sell
7,800
-2,600
-25% -$1.06M ﹤0.01% 2294
2025
Q4
$3.26M Buy
10,400
+200
+2% +$63.5K ﹤0.01% 2664
2025
Q3
$2.75M Sell
10,200
-5,700
-36% -$1.31M ﹤0.01% 2724
2025
Q2
$3.51M Buy
15,900
+6,700
+73% +$1.21M ﹤0.01% 2302
2025
Q1
$1.21M Buy
9,200
+7,500
+441% +$1.05M ﹤0.01% 2973
2024
Q4
$233K Buy
+1,700
New +$234K ﹤0.01% 4012
2014
Q2
Sell
-30,000
Closed -$892K 4142
2014
Q1
$892K Buy
+30,000
New +$863K ﹤0.01% 3133

Other funds holding AGX

David Shaw's AGX Position: Q2 2026 in Review

David Shaw reduced its Argan (AGX) stake by 70% in Q2 2026, selling an estimated $5.85M and leaving 3,710 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2859.

David Shaw first reported a position in AGX in Q2 2014 and has held it in 19 quarters since. The position peaked at $6.81M in Q1 2026. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • David Shaw held 3,710 shares of Argan worth $2.96M as of Q2 2026.
  • David Shaw sold 8,789 Argan shares in Q2 2026, an estimated $5.85M.
  • Argan made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2859 holding.
  • David Shaw first reported a position in Argan in Q2 2014 and has held it in 19 quarters since.
  • David Shaw's Argan position peaked at $6.81M in Q1 2026.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.